Stryker Revenue 2010-2023 | SYK

Stryker annual/quarterly revenue history and growth rate from 2010 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Stryker revenue for the quarter ending December 31, 2023 was $5.815B, a 11.78% increase year-over-year.
  • Stryker revenue for the twelve months ending December 31, 2023 was $20.498B, a 11.11% increase year-over-year.
  • Stryker annual revenue for 2023 was $20.498B, a 11.11% increase from 2022.
  • Stryker annual revenue for 2022 was $18.449B, a 7.84% increase from 2021.
  • Stryker annual revenue for 2021 was $17.108B, a 19.21% increase from 2020.
Stryker Annual Revenue
(Millions of US $)
2023 $20,498
2022 $18,449
2021 $17,108
2020 $14,351
2019 $14,884
2018 $13,601
2017 $12,444
2016 $11,325
2015 $9,946
2014 $9,675
2013 $9,021
2012 $8,657
2011 $8,307
2010 $7,320
2009 $6,723
Stryker Quarterly Revenue
(Millions of US $)
2023-12-31 $5,815
2023-09-30 $4,909
2023-06-30 $4,996
2023-03-31 $4,778
2022-12-31 $5,202
2022-09-30 $4,479
2022-06-30 $4,493
2022-03-31 $4,275
2021-12-31 $4,701
2021-09-30 $4,160
2021-06-30 $4,294
2021-03-31 $3,953
2020-12-31 $4,262
2020-09-30 $3,737
2020-06-30 $2,764
2020-03-31 $3,588
2019-12-31 $4,131
2019-09-30 $3,587
2019-06-30 $3,650
2019-03-31 $3,516
2018-12-31 $3,796
2018-09-30 $3,242
2018-06-30 $3,322
2018-03-31 $3,241
2017-12-31 $3,471
2017-09-30 $3,006
2017-06-30 $3,012
2017-03-31 $2,955
2016-12-31 $3,157
2016-09-30 $2,833
2016-06-30 $2,840
2016-03-31 $2,495
2015-12-31 $2,715
2015-09-30 $2,420
2015-06-30 $2,432
2015-03-31 $2,379
2014-12-31 $2,618
2014-09-30 $2,389
2014-06-30 $2,363
2014-03-31 $2,305
2013-12-31 $2,468
2013-09-30 $2,151
2013-06-30 $2,212
2013-03-31 $2,190
2012-12-31 $2,338
2012-09-30 $2,052
2012-06-30 $2,106
2012-03-31 $2,161
2011-12-31 $2,215
2011-09-30 $2,031
2011-06-30 $2,046
2011-03-31 $2,015
2010-12-31 $1,995
2010-09-30 $1,768
2010-06-30 $1,758
2010-03-31 $1,799
2009-12-31 $1,834
2009-09-30 $1,653
2009-06-30 $1,634
2009-03-31 $1,601
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $132.712B $20.498B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $197.928B 25.68
Medtronic (MDT) Ireland $112.249B 15.87
Boston Scientific (BSX) United States $96.425B 32.11
EssilorLuxottica (ESLOY) France $91.547B 0.00
Lonza Group Ag (LZAGY) Switzerland $38.605B 0.00
Haleon (HLN) United Kingdom $37.954B 0.00
Terumo (TRUMY) Japan $27.163B 38.24
ResMed (RMD) United States $26.544B 26.54
Zimmer Biomet Holdings (ZBH) United States $26.062B 16.50
Baxter (BAX) United States $20.933B 15.27
Koninklijke Philips (PHG) Netherlands $18.861B 15.04
Insulet (PODD) United States $13.338B 102.14
Smith & Nephew SNATS (SNN) United Kingdom $12.267B 0.00
Demant (WILYY) Denmark $11.676B 0.00
Bio-Rad Laboratories (BIO) United States $9.925B 28.93
BellRing Brands (BRBR) United States $7.379B 39.68
Perrigo (PRGO) Ireland $4.340B 12.97
GN Store Nord (GNNDY) Denmark $3.997B 25.88
Lantheus Holdings (LNTH) United States $3.935B 10.76
Envista Holdings (NVST) United States $3.865B 14.73
Neogen (NEOG) United States $3.819B 36.75
Haemonetics (HAE) United States $3.675B 18.80
Prestige Consumer Healthcare (PBH) United States $3.433B 16.23
Green Thumb Industries (GTBIF) United States $2.924B 73.16
QuidelOrtho (QDEL) United States $2.790B 10.14
ICU Medical (ICUI) United States $2.572B 18.96
Verano Holdings (VRNOF) United States $2.147B 0.00
TG Therapeutics (TGTX) United States $2.094B 0.00
InMode (INMD) Israel $1.915B 9.91
National Vision Holdings (EYE) United States $1.633B 56.40
Owens & Minor (OMI) United States $1.623B 22.33
AtriCure (ATRC) United States $1.551B 0.00
Agios Pharmaceuticals (AGIO) United States $1.490B 0.00
Warby Parker (WRBY) United States $1.420B 0.00
LeMaitre Vascular (LMAT) United States $1.393B 51.27
Jin Medical (ZJYL) China $1.375B 0.00
Maravai LifeSciences Holdings (MRVI) United States $1.334B 17.70
MacroGenics (MGNX) United States $1.072B 0.00
AdaptHealth (AHCO) United States $1.022B 20.24
Quanterix (QTRX) United States $0.991B 0.00
BioLife Solutions (BLFS) United States $0.777B 0.00
Evolus (EOLS) United States $0.773B 0.00
VAREX IMAGING (VREX) United States $0.695B 15.03
Cresco Labs (CRLBF) United States $0.599B 0.00
PetIQ (PETQ) United States $0.554B 21.17
Valneva SE (VALN) France $0.554B 0.00
ZimVie (ZIMV) United States $0.549B 31.35
OraSure Technologies (OSUR) United States $0.496B 8.65
TerrAscend (TSNDF) Canada $0.492B 0.00
Phibro Animal Health (PAHC) United States $0.489B 10.59
Surmodics (SRDX) United States $0.445B 48.14
Zynex (ZYXI) United States $0.431B 29.56
Cerus (CERS) United States $0.428B 0.00
Canopy Growth (CGC) Canada $0.348B 0.00
Biote (BTMD) United States $0.341B 3.23
Sanara MedTech (SMTI) United States $0.333B 0.00
Viemed Healthcare (VMD) United States $0.332B 37.65
Omeros (OMER) United States $0.307B 0.00
Utah Medical Products (UTMD) United States $0.263B 15.84
TriSalus Life Sciences (TLSI) United States $0.238B 0.00
Aurora Cannabis (ACB) Canada $0.214B 0.00
Organigram Holdings (OGI) Canada $0.205B 0.00
Quipt Home Medical (QIPT) United States $0.188B 0.00
Ayr Wellness (AYRWF) United States $0.150B 0.00
High Tide (HITI) Canada $0.148B 0.00
Fonar (FONR) United States $0.146B 12.52
Allurion Technologies (ALUR) United States $0.134B 0.00
Jushi Holdings (JUSHF) United States $0.129B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.127B 0.00
Zevia PBC (ZVIA) United States $0.113B 0.00
Brainsway (BWAY) Israel $0.113B 0.00
Capricor Therapeutics (CAPR) United States $0.111B 0.00
Safety Shot (SHOT) United States $0.110B 0.00
MariMed (MRMD) United States $0.105B 0.00
Chimerix (CMRX) United States $0.102B 0.00
FitLife Brands (FTLF) United States $0.099B 19.45
Eagleford Energy (GRUSF) United States $0.087B 47.97
Apyx Medical (APYX) United States $0.080B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.078B 5.06
Veru (VERU) United States $0.067B 0.00
Societal CDMO (SCTL) United States $0.052B 0.00
United Health Products (UEEC) United States $0.052B 0.00
Cytosorbents (CTSO) United States $0.045B 0.00
Cellectar Biosciences (CLRB) United States $0.042B 0.00
Bright Green (BGXX) United States $0.041B 0.00
ImmuCell (ICCC) United States $0.040B 0.00
United-Guardian (UG) United States $0.040B 15.65
Rockwell Medical (RMTI) United States $0.038B 0.00
Modular Medical (MODD) United States $0.038B 0.00
Nephros (NEPH) United States $0.037B 0.00
Exagen (XGN) United States $0.036B 0.00
FSD PHARMA (HUGE) Canada $0.033B 0.00
Agape ATP (ATPC) $0.032B 0.00
Meihua Medical Technologies (MHUA) China $0.021B 0.00
Trinity Biotech (TRIB) Ireland $0.020B 0.00
ProSomnus (OSA) United States $0.012B 0.00
GUARDION HEALTH (GHSI) United States $0.011B 0.00
Leafly Holdings (LFLY) United States $0.008B 0.00
Flora Growth (FLGC) United States $0.008B 0.00
Innovative Eyewear (LUCY) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.004B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.001B 0.00
Senestech (SNES) United States $0.000B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
InterCure (INCR) Israel $0.000B 13.85
SNDL (SNDL) Canada $0.000B 0.00